Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Mixed Results for Cannabis Initiatives in U.S. States

LOS ANGELES- In the recent elections, U.S. states voted on a range of cannabis-related measures, with mixed results. Notably, attempts to expand cannabis access faced both advancements and setbacks, highlighting the varied landscape of cannabis ...

Willow Biosciences Posts Record Revenue in Q2

LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing in pharmaceutical ingredients, reported record revenue of $1 million for the second quarter of 2024, a 660% increase compared to the same period last year. ...

Week’s In Review: Trump’s Return to Office: What it Means for the Cannabis Industry; Planet 13 Launches Initiative to Support Florida Veterans and First Responders with Medical Cannabis Access; Mixed Results for Cannabis Initiatives in U.S. States; Texas Voters Approve Local Cannabis Decriminalization in Dallas, Bastrop, and Lockhart

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: Criticism Mounts Over New York’s Social Equity Cannabis Fund for High Costs and Limited Impact; Arizona to Launch Recreational Cannabis Home Delivery; DeSantis Uses Opioid Settlement Funds for Anti-Cannabis Ads Ahead of Ballot Initiative

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: New Hampshire Senate Blocks Cannabis Greenhouse Bill Despite Overwhelming House Support; Tilray Reports 13% Decline in Cannabis Revenue for Q1 FY25; Missouri Health Department Requests $877K to Enforce Hemp Product Ban

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...

Week’s In Review: New York Cannabis Market Report Highlights Progress and Challenges; TerrAscend Secures Additional $26 Million in Loan Draw to Pay Down High-Interest Debt; Harris’s Comments Over Cannabis Reform in the 2024 Presidential Race; FBI Data: Over 200,000 Arrests for Cannabis Possession in 2023

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...

Week’s In Review: California Permits Lounges; Los Angeles County Targets Unlicensed Cannabis Dispensaries with “Deplatforming” Motion; California Bans Hemp-Derived THC Products Amid Regulatory Concerns; California’s New Hemp Regulations Raise Concerns for Industry and Consumers

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...

Week’s In Review: TerrAscend Corp. Announces $10 Million Share Buyback Program; Bipartisan Lawmakers Push for MDMA Therapy for PTSD as FDA Decision Looms; Verano Acquires Cannabist Company’s Operations in Arizona and Virginia for $105 Million

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...

Ascend Wellness Expands Recreational Cannabis Sales in Ohio

LOS ANGELES- Ascend Wellness Holdings, Inc.  a cannabis operator, announced the expansion of recreational cannabis sales in Ohio to its fifth dispensary in Carroll. The move comes after the company successfully transitioned four other locations—Cincinnati, ...

Rubicon Organics Reports Q2 2024 Financial Results

LOS ANGELES- Rubicon Organics Inc. a licensed producer specializing in organic and premium cannabis, released its financial results for the second quarter ending June 30, 2024. The company reported record net revenue of CAD 12.1 ...

Filament Health Reports Q2 2024 Results

LOS ANGELES- Filament Health Corp, a clinical psychedelic drug development company, has released its financial results for the second quarter ending June 30, 2024. The company highlighted its progress in advancing drug candidates targeting substance ...

Subscribe To Our Newsletter

Go to Top